한글목차

효모감염증 치료 동향 및 전망

세계 효모감염증 치료 시장은 2024년부터 2030년까지 4.6%의 CAGR로 2030년까지 약 79억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 자가 면역 질환 및 효모 감염의 증가, 감염성 및 알레르기 질환의 발생률 증가, 효모 감염의 혁신적인 치료에 대한 정부의 자금 지원 증가입니다. 세계 효모감염증 치료 시장의 미래는 소매 약국/약국, 병원 약국, 전문점, 온라인 판매 시장에서 기회가 있어 유망한 것으로 보입니다.

부문별 효모균 감염증 치료

이 조사에는 치료 유형별, 적응증별, 제형별, 유통 채널별, 지역별 세계 효모감염증 치료 예측이 포함되어 있습니다.

효모감염증 치료 시장 인사이트

Lucintel은 정제/캡슐이 다양한 크기와 긴 저장 기간으로 인해 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

이 시장에서는 소매 약국/약국이 가장 큰 부문을 차지할 것으로 보입니다.

북미에서는 질 감염과 효모 감염의 빈도가 증가함에 따라 예측 기간 동안 가장 큰 지역으로 남아있을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 효모감염증 치료 시장은 2030년까지 약 79억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은?

A2. 세계 효모감염증 치료 시장은 2024년부터 2030년까지 연평균 4.6%의 CAGR로 성장할 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은?

A3. 이 시장의 주요 촉진요인은 자가 면역 질환 및 효모 감염의 증가, 감염 및 알레르기 질환의 발생률이 크게 증가하고, 효모 감염의 혁신적인 치료에 대한 정부의 자금 지원 증가입니다.

Q4. 시장의 주요 부문은?

A4. 세계 효모감염증 치료 시장의 미래는 소매 약국/약국, 병원 약국, 전문점, 온라인 판매 시장에서 유망한 기회가 있습니다.

Q5. 시장의 주요 기업은?

A5. 주요 효모감염증 치료 기업은 다음과 같습니다.

• Astellas Pharma
• Astra Zeneca
• Abbott Laboratories
• Allergan
• Brundavan Laboratories
• Bayer
• Corden Pharma
• Merck & Co
• Novartis
• Pfizer

Q6. 향후 가장 큰 시장 부문은?

A6. Lucintel은 정제/캡슐이 다양한 크기와 긴 저장 기간으로 인해 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은?

A7. 북미는 질 감염 및 효모 감염의 빈도가 증가함에 따라 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 효모감염증 치료 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 효모감염증 치료 시장 동향(2018-2023년)과 예측(2024-2030년)
• 치료 유형별 세계의 효모감염증 치료 시장
  • 아졸
  • 폴리진
  • 에키노칸딘
  • 기타
• 적응증별 세계의 효모감염증 치료 시장
  • 성기 칸디다증
  • 침습성 칸디다증
  • 구강인두/식도 칸디다증
  • 기타
• 제형별 세계의 효모감염증 치료 시장
  • 분말
  • 크림/연고
  • 정제/캡슐
  • 기타
• 유통 채널별 세계의 효모감염증 치료 시장
  • 소매 약국/드럭스토어
  • 병원 약국
  • 전문점
  • 온라인 판매
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 효모감염증 치료 시장
• 북미의 효모감염증 치료 시장
• 유럽의 효모감염증 치료 시장
• 아시아태평양 효모감염증 치료 시장
• 기타 지역 효모감염증 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 치료 유형별 세계의 효모감염증 치료 시장 성장 기회
  • 적응증별 세계의 효모감염증 치료 시장 성장 기회
  • 제형별 세계의 효모감염증 치료 시장 성장 기회
  • 유통 채널별 세계의 효모감염증 치료 시장 성장 기회
  • 지역별 세계의 효모감염증 치료 시장 성장 기회
• 세계의 효모감염증 치료 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 효모감염증 치료 시장 능력 확대
  • 세계의 효모감염증 치료 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Astellas Pharma
• Astra Zeneca
• Abbott Laboratories
• Allergan
• Brundavan Laboratories
• Bayer
• Corden Pharma
• Merck & Co
• Novartis
• Pfizer

영문목차

Yeast Infection Treatment Trends and Forecast

The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets. The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Yeast Infection Treatment by Segment

The study includes a forecast for the global yeast infection treatment by treatment type, indication, form, distribution channel, and region.

Yeast Infection Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

• Azoles
• Polygene
• Echinocandin
• Others

Yeast Infection Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Genital Candidiasis
• Invasive Candidiasis
• Oropharyngeal/Esophageal Candidiasis
• Others

Yeast Infection Treatment Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Powders
• Creams/Ointments
• Tablets/Capsules
• Others

Yeast Infection Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacies/Drug Stores
• Hospital Pharmacies
• Specialty Stores
• Online Sales
• Others

Yeast Infection Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Yeast Infection Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies yeast infection treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the yeast infection treatment companies profiled in this report include-

• Astellas Pharma
• Astra Zeneca
• Abbott Laboratories
• Allergan
• Brundavan Laboratories
• Bayer
• Corden Pharma
• Merck & Co
• Novartis
• Pfizer

Yeast Infection Treatment Market Insights

Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Within this market, retail pharmacy/drug store will remain the largest segment.

North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Features of the Global Yeast Infection Treatment Market

Market Size Estimates: Yeast infection treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Yeast infection treatment market size by treatment type, indication, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Yeast infection treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment type, indication, form, distribution channel, and regions for the yeast infection treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the yeast infection treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the yeast infection treatment market size?

Answer: The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030.

Q2. What is the growth forecast for yeast infection treatment market?

Answer: The global yeast infection treatment market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the yeast infection treatment market?

Answer: The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

Q4. What are the major segments for yeast infection treatment market?

Answer: The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets.

Q5. Who are the key yeast infection treatment market companies?

Answer: Some of the key yeast infection treatment companies are as follows:

• Astellas Pharma
• Astra Zeneca
• Abbott Laboratories
• Allergan
• Brundavan Laboratories
• Bayer
• Corden Pharma
• Merck & Co
• Novartis
• Pfizer

Q6. Which yeast infection treatment market segment will be the largest in future?

Answer: Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Q7. In yeast infection treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the yeast infection treatment market by treatment type (azoles, polygene, echinocandin, and others), indication (genital candidiasis, invasive candidiasis, oropharyngeal/esophageal candidiasis, and others), form (powders, creams/ointments, tablets/capsules, and others), distribution channel (retail pharmacies/drug stores, hospital pharmacies, specialty stores, online sales, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Yeast Infection Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Yeast Infection Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Yeast Infection Treatment Market by Treatment Type
  • 3.3.1: Azoles
  • 3.3.2: Polygene
  • 3.3.3: Echinocandin
  • 3.3.4: Others
• 3.4: Global Yeast Infection Treatment Market by Indication
  • 3.4.1: Genital Candidiasis
  • 3.4.2: Invasive Candidiasis
  • 3.4.3: Oropharyngeal/Esophageal Candidiasis
  • 3.4.4: Others
• 3.5: Global Yeast Infection Treatment Market by Form
  • 3.5.1: Powders
  • 3.5.2: Creams/Ointments
  • 3.5.3: Tablets/Capsules
  • 3.5.4: Others
• 3.6: Global Yeast Infection Treatment Market by Distribution Channel
  • 3.6.1: Retail Pharmacies/Drug Stores
  • 3.6.2: Hospital Pharmacies
  • 3.6.3: Specialty Stores
  • 3.6.4: Online Sales
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Yeast Infection Treatment Market by Region
• 4.2: North American Yeast Infection Treatment Market
  • 4.2.1: North American Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
  • 4.2.2: North American Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
• 4.3: European Yeast Infection Treatment Market
  • 4.3.1: European Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
  • 4.3.2: European Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
• 4.4: APAC Yeast Infection Treatment Market
  • 4.4.1: APAC Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
  • 4.4.2: APAC Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
• 4.5: ROW Yeast Infection Treatment Market
  • 4.5.1: ROW Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
  • 4.5.2: ROW Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Yeast Infection Treatment Market by Treatment Type
  • 6.1.2: Growth Opportunities for the Global Yeast Infection Treatment Market by Indication
  • 6.1.3: Growth Opportunities for the Global Yeast Infection Treatment Market by Form
  • 6.1.4: Growth Opportunities for the Global Yeast Infection Treatment Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Yeast Infection Treatment Market by Region
• 6.2: Emerging Trends in the Global Yeast Infection Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Yeast Infection Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Yeast Infection Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Astellas Pharma
• 7.2: Astra Zeneca
• 7.3: Abbott Laboratories
• 7.4: Allergan
• 7.5: Brundavan Laboratories
• 7.6: Bayer
• 7.7: Corden Pharma
• 7.8: Merck & Co
• 7.9: Novartis
• 7.10: Pfizer